Nadav Friedmann is Chief Medical Officer of CASSAVA SCIENCES INC. Currently has a direct ownership of 79,910 shares of SAVA, which is worth approximately $2.25 Million. The most recent transaction as insider was on Oct 03, 2022, when has been sold 9,376 shares (Common Stock) at a price of $0.95 per share, resulting in proceeds of $8,907. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 79.9K
0% 3M change
0% 12M change
Total Value Held $2.25 Million

NADAV FRIEDMANN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 03 2022
BUY
Exercise of conversion of derivative security
$8,907 $0.95 p/Share
9,376 Added 10.5%
79,910 Common Stock
May 27 2022
SELL
Payment of exercise price or tax liability
$655,010 $26.66 p/Share
24,569 Reduced 25.83%
70,534 Common Stock
May 27 2022
BUY
Exercise of conversion of derivative security
$654,967 $23.38 p/Share
28,014 Added 22.75%
95,103 Common Stock
Mar 17 2021
SELL
Payment of exercise price or tax liability
$1,500,230 $62.52 p/Share
23,996 Reduced 25.96%
68,429 Common Stock
Mar 17 2021
BUY
Exercise of conversion of derivative security
$1,500,203 $53.55 p/Share
28,015 Added 23.26%
92,428 Common Stock
NF

Nadav Friedmann

Chief Medical Officer
Austin, TX

Track Institutional and Insider Activities on SAVA

Follow CASSAVA SCIENCES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SAVA shares.

Notify only if

Insider Trading

Get notified when an Cassava Sciences Inc insider buys or sells SAVA shares.

Notify only if

News

Receive news related to CASSAVA SCIENCES INC

Track Activities on SAVA